Putting Digital Therapeutics to Change Future of Healthcare

What are digital therapeutics?

A new trend out of the fast-growing mobile health (mHealth) market for life sciences, digital therapeutics are software products used in the treatment of medical conditions. A growing number of start-ups and well-established technology companies are introducing innovative applications designed to enable patients to take greater control of their care. They are similar to customer wellness apps, but with one key difference: Digital therapeutics focus on delivering clinical outcomes.

Better health care through digital therapeutics

Digital therapeutics have the potential to address unmet patient needs that traditional treatments and therapies have been unable to provide. Companies that are able to leverage life sciences technology to address these gaps, in combination with faster product development timelines, could gain a significant advantage over traditional life sciences companies.

For pharmaceutical and medtech companies, digital therapeutics offer a way to differentiate products with a relatively low capital investment, especially compared to the R&D costs normally associated with a drug or medical device. Digital therapeutics also offer an opportunity to extend product life cycles, differentiate products in development, and fill in any gaps in the market for traditional medicine.

Digital Therapeutics Market Size to Hit $13.80 Billion by 2027, Says Allied Market Research

Increase in implementation of smartphones and tablets along with healthcare apps, surge in incidences of chronic diseases, and growth in need to control healthcare costs propel the growth of the global digital therapeutics market. The market across North America region has dominated in 2019 and would continue to lead throughout the forecast period. However, Asia-Pacific would manifest the fastest growth rate in between 2019 to 2027.

Download Detailed COVID-19 Impact Sample Report at: https://www.alliedmarketresearch.com/request-for-customization/1674?reqfor=covid

As per the report, the global Digital Therapeutics Market was pegged at $2.88 billion in 2019, and is projected to reach $13.80 billion by 2027, growing at a CAGR of 20.5% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and fluctuating market trends.

Increase in implementation of smartphones and tablets along with healthcare apps, surge in incidences of chronic diseases, and growth in need to control healthcare costs propel the growth of the global digital therapeutics market. On the other hand, lack of awareness regarding digital therapeutics in emerging economies and concerns regarding data privacy restrain the growth to certain extent. Conversely, emerging markets across developing countries are anticipated to usher a number of opportunities in the future.